Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata

被引：0

作者：

Shapiro, Jerry ^{[1
]}

Ko, Justin ^{[2
]}

Egeberg, Alexander ^{[3
]}

Somani, Najwa ^{[4
]}

Jedynak, Jakub ^{[4
]}

Torisu-Itakura, Hitoe ^{[4
]}

Yu, Guanglei ^{[4
]}

Lu, Na ^{[5
]}

Craiglow, Brittany ^{[6
]}

机构：

[1] New York Univ, Grossman Sch Med, New York, NY USA

[2] Stanford Med, Stanford, CA USA

[3] Copenhagen Univ Hosp Bispebjerg, Copenhagen, Denmark

[4] Eli Lilly & Co, Indianapolis, IN USA

[5] Precis Stat Consulting, Woodbury, MN USA

[6] Yale Sch Med, New Haven, CT USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

41247

引用

页码：AB127 / AB127

页数：1

共 50 条

[31] Temporary hair loss simulating alopecia areata after endovascular surgery of cerebral arteriovenous malformations: A report of 3 cases
Tosti, A
Piraccini, BM
Alagna, G
ARCHIVES OF DERMATOLOGY, 1999, 135 (12) : 1555 - 1556
[32] Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study
Tziotzios, C.
Sinclair, R.
Lesiak, A.
Mehlis, S.
Kinoshita-Ise, M.
Tsianakas, A.
Luo, X.
Law, E. H.
Ishowo-Adejumo, R.
Wolk, R.
Sadrarhami, M.
Lejeune, A.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025,
[33] Development of Autoimmune Hair Loss Disease Alopecia Areata Is Associated with Cardiac Dysfunction in C3H/HeJ Mice
Wang, Eddy
Chong, Katy
Yu, Mei
Akhoundsadegh, Noushin
Granville, David J.
Shapiro, Jerry
McElwee, Kevin J.
PLOS ONE, 2013, 8 (04):
[34] Distinguishing diffuse alopecia areata (AA) from pattern hair loss (PHL) using CD3+ T cells
Kolivras, Athanassios
Thompson, Curtis
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : 937 - 944
[35] Successful topical immunotherapy of alopecia areata-like hair loss in C3H/HeJ-mice.
Freyschmidt-Paul, P
Sundberg, JP
McElwee, K
Happle, R
Boggess, D
Hoffmann, R
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 659 - 659
[36] Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
Mostaghimi, Arash
Mesinkovska, Natasha Atanaskova
Senna, Maryanne Makredes
King, Brett
Hamilton, Colleen
Cassella, James
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB164 - AB164
[37] The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
Heather L. Gelhorn
Katelyn Cutts
Emily Edson-Heredia
Peter Wright
Amy Delozier
Jerry Shapiro
Maryanne Senna
Antonella Tosti
Dermatology and Therapy, 2022, 12 : 989 - 997
[38] The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
Gelhorn, Heather L.
Cutts, Katelyn
Edson-Heredia, Emily
Wright, Peter
Delozier, Amy
Shapiro, Jerry
Senna, Maryanne
Tosti, Antonella
DERMATOLOGY AND THERAPY, 2022, 12 (04) : 989 - 997
[39] Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials
Mesinkovska, Natasha Atanaskova
Ito, Taisuke
Senna, Maryanne
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB50 - AB50
[40] Efficacy of baricitinib in adults with alopecia areata: patients' perspectives on hair regrowth from two phase III randomized controlled trials (BRAVE-AA1 and BRAVE-AA2)
Bewley, Anthony
Kwon, Ohsang
Zlotogorski, Abraham
Ito, Taisuke
Foley, Peter
Petto, Helmut
Dutronc, Yves
McKenzie, Robert
Durand, Frederick
King, Brett
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 70 - 71

← 1 2 3 4 5 →